Menopause, Laughter Therapy, and Well-Being
The Effect of Laughter Therapy on Brain Fog, Psychological Well-Being, and Sleep Quality in Women During Menopause
2 other identifiers
interventional
97
1 country
1
Brief Summary
The intervention will be conducted by Assist. Prof. Dr. Nurten ÖZÇALKAP. No invasive procedures will be performed; participants will engage in deep breathing, warm-up exercises, playful activities, and laughter exercises. The researcher holds an internationally certified training in laughter therapy. Intervention Group Participants will be invited face-to-face, informed about the study, and provide consent. They will be assigned to groups of 8 - 9 and receive laughter yoga twice weekly for a total of 8 sessions (20-40 minutes each) in a suitable hospital or institutional setting. Baseline assessments will include the Introductory Information Form, Brain Fog Scale, Psychological Well-Being Scale, and Sleep Quality Scale. These scales will be re-administered after the 8th session. Control Group Participants will be recruited similarly and provide consent. Baseline assessments will be conducted using the same instruments. Post-test assessments will be performed 4 weeks later. After study completion, control group participants who wish will be offered one session of laughter yoga.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
April 4, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedApril 22, 2026
April 1, 2026
3 months
April 4, 2026
April 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Introductory Information Form:
This form was developed by the researchers based on the literature and includes questions on participants' sociodemographic characteristics.
Baseline
Brain Fog Scale
This scale consists of 30 items and three subdimensions. The total score ranges from 30 to 150. The cognitive symptoms subscale ranges from 17 to 85, the physical symptoms subscale from 8 to 40, and the psychological symptoms subscale from 5 to 25. Higher scores on the total scale and/or subscales indicate greater levels of brain fog.
Baseline, After 4 weeks
Psychological Well-Being Scale
Developed by Diener et al. and adapted into Turkish by Telef, this scale consists of eight items. The items assess components such as individuals' sense of competence, quality of relationships, and life evaluation. The scale contains no reverse-scored items and uses a 7-point Likert format ranging from 1 (strongly agree) to 7 (strongly disagree). The total score ranges from 8 to 56, with higher scores indicating higher psychological well-being. Six items assess core dimensions of well-being, while two items contribute to score balance. The Cronbach's alpha coefficient of the scale was reported as 0.87.
Baseline, After 4 weeks
Pittsburgh Sleep Quality Index (PSQI)
The PSQI was developed in 1989, and its validity and reliability in Türkiye were established in 1996. It assesses sleep quality and disturbances over a one-month period. The index includes 24 items; however, item 19 and the last five items are used for clinical information only and are not included in scoring. The remaining 18 self-reported items evaluate seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each component is scored between 0 and 3, and the sum of these yields a global PSQI score ranging from 0 to 21. A total score above 5 indicates poor sleep quality, while a score of 5 or below indicates good sleep quality. The Cronbach's alpha coefficient of the scale was reported as 0.80.
Baseline, After 4 weeks
Study Arms (2)
Group 1 laughter yoga therapy
EXPERIMENTALParticipants received a total of 8 sessions of laughter yoga therapy, conducted twice weekly.
Group 2 Control
NO INTERVENTIONInterventions
Participants received a total of 8 sessions of laughter yoga therapy, conducted twice weekly.
Eligibility Criteria
You may qualify if:
- Willingness to participate in the study
- Ability to communicate
- Having entered menopause within the last 3 years
- Having experienced natural menopause
- Being literate
You may not qualify if:
- Having undergone surgical menopause
- Having a serious psychiatric or neurological disorder (e.g., schizophrenia, bipolar disorder, dementia, epilepsy)
- Having a chronic disease that may significantly affect overall quality of life and cognitive functions
- Having a physical condition that prevents participation in laughter therapy sessions (e.g., respiratory distress, vertigo, incontinence, severe cardiac disease)
- Using antidepressants or engaging in other non-pharmacological methods to reduce stress
- Receiving hormone replacement therapy
- Having experienced a traumatic event within the past year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ağri İbrahim Çeçen Universty
Ağrı, Ağri, 04100, Turkey (Türkiye)
Related Publications (2)
Telef, B. B. (2013). Psikolojik İyi Oluş Ölçeği: Türkçeye uyarlama, geçerlik ve güvenirlik çalışması. Hacettepe Üniversitesi Eğitim Fakültesi Dergisi, 28(3), 374-384.
RESULTAtik D, Inel Manav A. A Scale Development Study: Brain Fog Scale. Psychiatr Danub. 2023 Spring;35(1):73-79. doi: 10.24869/psyd.2023.73.
PMID: 37060595RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asistant Professor
Study Record Dates
First Submitted
April 4, 2026
First Posted
April 13, 2026
Study Start
December 1, 2024
Primary Completion
March 1, 2025
Study Completion
June 30, 2025
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to ethical considerations and the need to protect participant confidentiality. The data contain sensitive personal information, and participants did not provide consent for public data sharing. However, anonymized data may be made available upon reasonable request to the corresponding author.